Bush Reelection Is "Very Good" For Drug Manufacturers, GSK Says
This article was originally published in The Pink Sheet Daily
Executive Summary
President Bush's reelection is good for the pharmaceutical industry because of his position on prescription drug importation, GlaxoSmithKline VP-Federal Government Relations Sally Walsh said Nov. 17